Jennifer Michaelson, the Chief Scientific Officer of $CGEM, sold 4,000 shares of the company on 01-22-2026 for an estimated $49,200. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.0% of their shares of this class of stock. Following this trade, they now own 128,635 shares of this class of $CGEM stock.
$CGEM Insider Trading Activity
$CGEM insiders have traded $CGEM stock on the open market 17 times in the past 6 months. Of those trades, 8 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $CGEM stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT LP LYNX1 has made 8 purchases buying 1,874,057 shares for an estimated $13,322,539 and 0 sales.
- JENNIFER MICHAELSON (Chief Scientific Officer) has made 0 purchases and 6 sales selling 15,386 shares for an estimated $178,319.
- NADIM AHMED (President and CEO) sold 9,922 shares for an estimated $99,319
- JEFFREY ALAN JONES (Chief Medical Officer) sold 4,632 shares for an estimated $44,791
- JACQUELYN L SUMER (Chief Legal Officer) sold 3,480 shares for an estimated $33,651
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CGEM Hedge Fund Activity
We have seen 81 institutional investors add shares of $CGEM stock to their portfolio, and 64 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LYNX1 CAPITAL MANAGEMENT LP added 1,365,248 shares (+31.0%) to their portfolio in Q3 2025, for an estimated $8,095,920
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 928,539 shares (-24.1%) from their portfolio in Q3 2025, for an estimated $5,506,236
- PATIENT SQUARE CAPITAL LP removed 868,897 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $5,152,559
- FRANKLIN RESOURCES INC removed 812,124 shares (-36.4%) from their portfolio in Q3 2025, for an estimated $4,815,895
- ROCK SPRINGS CAPITAL MANAGEMENT LP removed 668,233 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $3,962,621
- CITADEL ADVISORS LLC removed 629,286 shares (-24.1%) from their portfolio in Q3 2025, for an estimated $3,731,665
- FORESITE CAPITAL MANAGEMENT VI LLC removed 594,025 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $3,522,568
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CGEM Analyst Ratings
Wall Street analysts have issued reports on $CGEM in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 01/08/2026
- Wedbush issued a "Outperform" rating on 12/09/2025
- BTIG issued a "Buy" rating on 11/24/2025
To track analyst ratings and price targets for $CGEM, check out Quiver Quantitative's $CGEM forecast page.
$CGEM Price Targets
Multiple analysts have issued price targets for $CGEM recently. We have seen 4 analysts offer price targets for $CGEM in the last 6 months, with a median target of $31.0.
Here are some recent targets:
- Robert Burns from HC Wainwright & Co. set a target price of $27.0 on 01/08/2026
- Robert Driscoll from Wedbush set a target price of $34.0 on 12/09/2025
- Julian Harrison from BTIG set a target price of $38.0 on 11/24/2025
- Jeffrey Hung from Morgan Stanley set a target price of $28.0 on 08/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
